Canada · Delayed Price · Currency is CAD Premium Brands Holdings Earnings Call Transcripts
Fiscal Year 2026
-
Organic growth in Specialty Foods slowed to 6% in Q2 due to deferred launches, but U.S. initiatives and Stampede sales remain strong. Adjusted EBITDA guidance was lowered, driven entirely by timing, not business weakness, and positive free cash flow is expected to accelerate as CapEx declines.
-
Record quarterly sales and EBITDA were driven by acquisitions, organic growth, and price increases, with net earnings up 154% year-over-year. U.S. segment growth and new product launches fueled results, while CapEx and debt ratios improved.
-
Capacity expansion and operational improvements position the business for strong growth, with high single-digit organic volume growth expected in specialty foods and significant free cash flow improvement forecast for 2026. Margin expansion and deleveraging remain key priorities.
-
Record Q1 sales and EBITDA driven by strong U.S. growth and acquisitions, with guidance unchanged for 2026. Debt ratios and cash flow are improving as major investments near completion.
Fiscal Year 2025
-
Revenue guidance for 2026 is CAD 9.4 billion, up 26% year-over-year, with growth led by U.S. initiatives and strong specialty foods performance. Margin normalization is expected by Q2, restructuring costs will decline, and leverage is targeted below 3x by end of 2026.
-
Sales grew 15.6% to CAD 7.5B in 2025, with adjusted EBITDA up 13.2% despite record-high beef costs. The Stampede acquisition and U.S. expansion drove growth, while the sale of Shaw Bakers and major CapEx investments position the company for future gains.
-
Q3 saw robust organic volume growth, led by U.S. specialty foods and a major product launch, with continued bullish outlook for 2026 as new capacity is leveraged. Margin improvement is expected as beef cost pressures ease and overhead is absorbed, while deleveraging remains a priority.
-
Q3 2025 saw record sales and free cash flow, with strong organic growth in U.S. premium protein, sandwich, and bakery segments. Despite high beef costs and supply disruptions, profitability and liquidity improved, and the company remains on track for its 2027 targets.
-
Strong organic growth and robust U.S. launches are driving a positive outlook, with a major product launch in September expected to boost Q4. Margin normalization is anticipated as commodity costs ease, while tariff and beef price uncertainties remain key risks.
-
Strong organic growth and robust U.S. pipeline are driving higher guidance for 2025, with major new facility launches and product rollouts expected to boost Q4. Margin normalization is anticipated as commodity costs ease, while capital allocation remains focused on debt reduction and potential share buybacks.
-
Strong Q1 performance was driven by robust U.S. organic growth, capacity investments, and high protein demand, with annual revenue growth guidance of 11–14% reaffirmed. Margin pressures from commodity inflation are expected to ease in the second half as price increases take effect.
-
Revenue rose 14.9% YoY to a record CAD 1.68B, with U.S. initiatives driving organic growth. Adjusted EBITDA increased 12.8%, while margin slipped 20 bps amid raw-material inflation and acquisition mix.
Fiscal Year 2024
-
2025 guidance projects strong organic growth, mainly from U.S. programs, with robust contribution margins and record free cash flow expected. Recent acquisitions are highly accretive, and capital allocation remains disciplined amid macro uncertainties.
-
Onboarding delays persist but the business pipeline remains robust, with up to CAD 1 billion in active U.S. opportunities for 2025. Specialty Foods and club channels show growth, while QSR and C-store headwinds are expected to stabilize. Capital expenditures will decline as major investments wind down.
-
Quarterly sales hit a record CAD 1.67 billion, up 1.3% year-over-year, with strong U.S. demand offset by a temporary sales decline in the sandwich group. Adjusted EBITDA rose slightly, while EPS fell due to higher costs. Significant growth opportunities and capital investments are expected to drive future performance.
-
Revenue guidance for 2024 is now at the lower end due to delayed U.S. product launches, but growth is expected to accelerate as large-scale rollouts proceed. Margin targets remain intact, with robust acquisition and CapEx activity supporting future expansion.
-
Record Q2 sales and EBITDA were driven by U.S. growth and operational efficiencies, though delayed product launches and a challenging consumer environment in Canada tempered results. Guidance for 2024 is maintained, with a higher likelihood of hitting the lower end of the range.